Quantcast

Latest Omacetaxine mepesuccinate Stories

2014-09-03 08:34:35

FLINT, Mich., Sept. 3, 2014 /PRNewswire/ -- Diplomat, the nation's largest independent specialty pharmacy, announced that it will be the exclusive distributor for SYNRIBO(®) (omacetaxine mepesuccinate) for subcutaneous injection intended for home use. On May 5, 2014, the U.S. Food and Drug Administration (FDA) expanded the indication of SYNRIBO(®) to allow for home administration. SYNRIBO(® )is a prescription medicine used to treat adult patients with chronic or accelerated phase...

2014-05-23 16:23:48

FLINT, Mich., May 23, 2014 /PRNewswire-iReach/ -- Diplomat, the nation's largest independent specialty pharmacy, announced that it will be distributing SYNRIBO(®) (omacetaxine mepesuccinate), now approved by the U.S. Food and Drug Administration for subcutaneous injection and home administration. SYNRIBO is a treatment for adults with chronic myeloid leukemia (CML) who are no longer responding to or are unable to tolerate two or more tyrosine kinase inhibitors (TKIs). The new...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'